{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:31:03Z","timestamp":1792024263939,"version":"4.4.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MHLW Comprehensive Research Project","award":["24FA1008"],"award-info":[{"award-number":["24FA1008"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A decade-long follow-up study identified metabolic dysfunction-associated fatty liver disease (MAFLD) as an independent predictor for the onset of chronic kidney disease (CKD). In 2023, a Delphi consensus introduced the term metabolic dysfunction-associated steatotic liver disease (MASLD) as an updated nomenclature. This study aims to evaluate whether MASLD, as the newly defined concept of steatotic liver disease, functions as an independent risk factor for CKD development. Additionally, the study seeks to examine the association between MASLD and CKD, while identifying contributing risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This research involved a retrospective cohort study conducted on individuals participating in health checkups at Asahi University Hospital, Japan, from 1994 to 2023. Logistic regression analysis was employed to investigate the relationship between MASLD and the incidence of CKD over a five-year follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 15,873 participants were included in this study. The incidence of CKD was highest among individuals with MASLD (9.5%). Multivariate analysis demonstrated that MASLD was significantly associated with an increased risk of CKD, with an odds ratio (OR) of 1.37 (95% CI 1.12\u20131.67, p\u2009=\u20090.002). Additional factors such as age (OR 1.04, 95% CI 1.03\u20131.05, p\u2009&lt;\u20090.001) and estimated glomerular filtration rate (eGFR) (OR 0.88, 95% CI 0.87\u20130.89, p\u2009&lt;\u20090.001) were also identified as significant predictors of CKD. These findings suggest a robust association between MASLD and an elevated risk of CKD compared to individuals without steatotic liver disease or cardiometabolic risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study establishes MASLD as a significant risk factor for CKD onset. Effective identification and management of MASLD cases are essential to mitigate the incidence of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0334720","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:36:06Z","timestamp":1760722566000},"page":"e0334720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Yuriko","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Obora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4445","authenticated-orcid":true,"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"1","key":"pone.0334720.ref001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"A Afshin","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0334720.ref002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0334720.ref003","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"A Mantovani","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"pone.0334720.ref004","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"S Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"pone.0334720.ref005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"M Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0334720.ref006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"M Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0334720.ref007","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ndt\/gfac188","article-title":"Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease","volume":"38","author":"M Tanaka","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0334720.ref008","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000696","article-title":"Reply: a multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"JV Lazarus","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"pone.0334720.ref009","doi-asserted-by":"crossref","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic liver disease, MASLD and risk of chronic kidney disease","volume":"50","author":"J Bilson","year":"2024","journal-title":"Diabetes Metab"},{"issue":"6","key":"pone.0334720.ref010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/hepr.14011","article-title":"Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease","volume":"54","author":"K Suzuki","year":"2024","journal-title":"Hepatol Res"},{"issue":"1","key":"pone.0334720.ref011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40001-023-01114-6","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)","volume":"28","author":"C Roderburg","year":"2023","journal-title":"Eur J Med Res"},{"issue":"6","key":"pone.0334720.ref012","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/nu15061540","article-title":"Alcohol consumption and a decline in glomerular filtration rate: the Japan Specific Health Checkups Study","volume":"15","author":"Y Kimura","year":"2023","journal-title":"Nutrients"},{"issue":"14","key":"pone.0334720.ref013","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors","volume":"293","author":"MG Shlipak","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"pone.0334720.ref014","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis","volume":"32","author":"JT Kelly","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"pone.0334720.ref015","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/hepr.13543","article-title":"Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan","volume":"50","author":"T Shida","year":"2020","journal-title":"Hepatol Res"},{"issue":"2","key":"pone.0334720.ref016","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040","volume":"15","author":"T Ito","year":"2021","journal-title":"Hepatol Int"},{"issue":"11","key":"pone.0334720.ref017","doi-asserted-by":"crossref","first-page":"101194","DOI":"10.1016\/j.jhepr.2024.101194","article-title":"Differential effects of low or high-fat dairy and fat derived from dairy products on MASLD","volume":"6","author":"O Tirosh","year":"2024","journal-title":"JHEP Rep"},{"issue":"11","key":"pone.0334720.ref018","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/ckj\/sfad151","article-title":"What is central to renal nutrition: protein or sodium intake?","volume":"16","author":"AYM Wang","year":"2023","journal-title":"Clin Kidney J"},{"issue":"6","key":"pone.0334720.ref019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose","volume":"22","author":"M Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"pone.0334720.ref020","doi-asserted-by":"crossref","DOI":"10.2337\/diab.45.3.S14","article-title":"Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study","volume":"45","author":"M Fujishima","year":"1996","journal-title":"Diabetes"},{"issue":"3","key":"pone.0334720.ref021","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2337\/diacare.26.3.688","article-title":"Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?","volume":"26","author":"Q Qiao","year":"2003","journal-title":"Diabetes Care"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:36:12Z","timestamp":1760722572000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334720"}},"subtitle":[],"editor":[{"given":"Anna","family":"Di Sessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334720","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}